Biohaven (BHVN) Prices 4.83M Shares at $51.75
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Biohaven Announces Pricing Of $250 Million Public Offering Of Common Shares
January 29, 2020 7:34 AM ESTNEW HAVEN, Conn., Jan. 29, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinicalstage biopharmaceutical company with a portfolio of innovative, latestage product candidates targeting neurological diseases, including rare disorders, today announced the pricing of its underwritten public offering of 4,830,917 of its common shares at a price to the public of $51.75 per share. In addition, Biohaven has granted the underwriter a 30-day option to purchase up to an... More
